Barinthus Biotherapeutics (BRNS) Net Income towards Common Stockholders Growth (3y) (2023 - 2026)
Barinthus Biotherapeutics (BRNS) Net Income towards Common Stockholders Growth (3y) (2023 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - | - |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - | 84.25% |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - | -10.84% |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn | 26.38% |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - | -46.86% |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - | 34.98% |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn | 13.80% |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - | - |
| 10 | Barinthus Biotherapeutics | 27.78 Mn | -39.33 Mn | - | 32.78% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 32.78% |
| Dec 31, 2025 | 19.35% |
| Sep 30, 2025 | -55.67% |
| Jun 30, 2025 | -49.58% |
| Mar 31, 2025 | -112.81% |
| Dec 31, 2024 | -7.19% |
| Sep 30, 2024 | -13.71% |
| Jun 30, 2024 | -0.17% |
| Mar 31, 2024 | -21.03% |
| Dec 31, 2023 | -12.13% |
| Sep 30, 2023 | -80.56% |
| Jun 30, 2023 | -76.46% |
| Mar 31, 2023 | -57.67% |